HS OBTAIN 17+
HS OBTAIN study with Sanofi
Hello Thread
Designed for iPad
-
- Free
Screenshots
Description
Your app for the HS OBTAIN study assessing the efficacy and safety of SAR442970 in participants with moderate to severe hidradenitis suppurativa.
This is the HS OBTAIN study with Sanofi assessing the efficacy and safety of an anti-TNF-OX40L NANOBODY molecule, SAR442970 in participants with moderate to severe hidradenitis suppurativa.
What’s New
Version 1.2.70
Bug Fix
App Privacy
The developer, Hello Thread, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Contact Info
- Usage Data
- Diagnostics
Privacy practices may vary based on, for example, the features you use or your age. Learn More
Information
- Provider
- Definitive Media Corp.
- Size
- 175.3 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 11.0 or later.
- iPad
- Requires iPadOS 11.0 or later.
- iPod touch
- Requires iOS 11.0 or later.
- Mac
- Requires macOS 11.0 or later and a Mac with Apple M1 chip or later.
- Apple Vision
- Requires visionOS 1.0 or later.
- Languages
-
English, Afrikaans, Amharic, Arabic, Belarusian, Bulgarian, Croatian, Czech, Danish, Dutch, Estonian, Finnish, French, Georgian, German, Greek, Gujarati, Hebrew, Hindi, Hungarian, Italian, Japanese, Kannada, Korean, Latvian, Lithuanian, Malay, Malayalam, Norwegian Bokmål, Polish, Portuguese, Romanian, Russian, Serbian, Sesotho, Setswana, Simplified Chinese, Slovak, Slovenian, Spanish, Swedish, Traditional Chinese, Turkish, Ukrainian, Vietnamese, Xhosa, Zulu
- Age Rating
- 17+ Frequent/Intense Medical/Treatment Information
- Copyright
- © 2024 THREAD
- Price
- Free